Publikationen von Udo Reichl
Alle Typen
Vortrag (253)
481.
Vortrag
Options for continuous production of cell culture-derived viral vaccines. Integrated Continuous Biomanufacturing, Castelldefels, Spain (2013)
482.
Vortrag
Human milk oligosaccharides: the unrivalled model for functional dietetic glycans. 7th Glycan Forum , Berlin, Germany (2013)
483.
Vortrag
Distributed Modeling and Parameter Estimation of Influenza Virus Replication During Vaccine Production. MATHMOD 2012 - 7th Vienna International Conference on Mathematical Modelling, Vienna, Austria (2012)
484.
Vortrag
Cell culture-based influenza virus production: suspension or adherent producer cell lines? Cell line development and engineering 2012, Cologne, Germany (2012)
485.
Vortrag
High cell density cultivations for influenza virus production using suspension cells. Vaccine Technology IV, Albufeira, Portugal (2012)
486.
Vortrag
Elucidating bottlenecks in influenza virus replication to optimize vaccine production. International Conference on the Systems Biology of Human Disease, Heidelberg, Germany (2012)
487.
Vortrag
Tailored sample preparation methods for xCGE-LIF based carbohydrate analysis. 23rd Joint Glycobiology Meeting 2012, Wageningen, The Netherlands (2012)
488.
Vortrag
A high-throughput assay to assess enzyme activity in central metabolism of production cell lines. Cell Culture Engineering XIII, Scottsdale, Arizona, USA (2012)
489.
Vortrag
Proteomanalyse der Virus-Wirtszell-Interaktion: Tollwutvirus-Replikation in einer Vero Zelllinie unter Einfluss zweier Zellkulturmedien. Biopharmazeutische Produktion 2012, Freiburg (2012)
490.
Vortrag
Insights into mammalian energy metabolism: connecting intracellular metabolites and maximum enzyme activities. GVC/DECHEMA Vortrags- und Diskussionstagung - Biopharmazeutische Produktion, Freiburg (2012)
491.
Vortrag
Cell Culture-derived Influenza Vaccine Production. Sächsische Akademie der Wisenschaften: Sitzung der Technikwissenschaftlichen Klasse, Leipzig (2012)
492.
Vortrag
Process Conditions can markedly affect the N-glycosylation pattern and immunogenicity of influenza A virus. ACTIP Meeting, Marburg (2012)
493.
Vortrag
Impact of process conditions on influenza A virus HA N-glycosylation and immunogenicity. ProcessNet-Jahrestagung und 30. DECHEMA-Jahrestagung der Biotechnologen, Karlsruhe (2012)
494.
Vortrag
Charakterisierung medizinisch-relevanter bakterieller Mischkulturen mittels t-RFLP und Durchflusszytometrie. ProcessNet Jahrestagung 2012 und 30. Jahrestagung der Biotechnologen, Karlsruhe, Germany (2012)
495.
Vortrag
Viability analysis of Lactobacillus plantarum by flow cytometry. ACHEMA 2012 Congress, Frankfurt, Germany (2012)
496.
Vortrag
Downstream Processing of Cell Culture-derived Virus Particles. ProcessNet-Membranverfahren in der Biotechnologie, Frankfurt am Main, Germany (2012)
497.
Vortrag
Gel-free metaproteome analysis of a biogas reactor. 1st International Conference on Biogas Microbiology, Leipzig, Germany (2011)
498.
Vortrag
Metaproteome analysis in environmental biotechnology. First international symposium on microbial resource management in biotechnology: concepts & applications, Genth, Belgium (2011)
499.
Vortrag
Influenza virus production: characteristics of different producer cell lines. 10th PEACe 2011, Cascais, Portugal (2011)
500.
Vortrag
Evaluation of a new cell line for vaccine production. Fourth International School on Production of Biologicals in Animal Cell Cultures, Rio de Janeiro, Brazil (2011)